New evidence-based non-statin treatment to lower LDL-c and CV risk
This video was recorded at the Congress of the American College of Cardiology (ACC) 2023 in New Orleans, LA, USA.
Peter Libby is a cardiovascular medicine specialist at Brigham and Women’s Hospital and the Mallinckrodt Professor of Medicine at Harvard Medical School.
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: